MetaADEDB 2.0 @ LMMD
Probenecid and colchicine
(WFUGJIWKCBYGJL-NTISSMGPSA-N)
Structure
SMILES
COc1c(OC)cc2c(c1OC)c1ccc(c(=O)cc1[C@H](CC2)NC(=O)C)OC.CCCN(S(=O)(=O)c1ccc(cc1)C(=O)O)CCC
Molecular Formula:
C35H44N2O10S
Molecular Weight:
684.796
Log P:
6.5388
Hydrogen Bond Acceptor:
12
Hydrogen Bond Donor:
2
TPSA:
166.15
CAS Number(s):
8055-45-6
Synonym(s)
1.
Probenecid and colchicine
External Link(s)
PubChem Compound44149770
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Toxicity to various agentsFAERS: 24US FAERS
2VomitingFAERS: 12US FAERS
3MyopathyFAERS: 9US FAERS
4NauseaFAERS: 8US FAERS
5Disseminated Intravascular CoagulationFAERS: 7US FAERS
6LeukocytosisFAERS: 6US FAERS
7Product use in unapproved indicationFAERS: 6US FAERS
8ThrombocytopeniaFAERS: 6US FAERS
9AlopeciaFAERS: 5US FAERS
10HypotensionFAERS: 5US FAERS
11OverdoseFAERS: 5US FAERS
12Product use issueFAERS: 5US FAERS
13RhabdomyolysisFAERS: 5US FAERS
14ShockFAERS: 5US FAERS
15Accidental exposure to productFAERS: 4US FAERS
16Completed SuicideFAERS: 4US FAERS
17PancytopeniaFAERS: 4US FAERS
18Abdominal PainFAERS: 3US FAERS
19Acute kidney injuryFAERS: 3US FAERS
20InfertilityFAERS: 3US FAERS
21Abdominal tendernessFAERS: 2US FAERS
22Blood creatine phosphokinase increasedFAERS: 2US FAERS
23BradycardiaFAERS: 2US FAERS
24CyanosisFAERS: 2US FAERS
25DehydrationFAERS: 2US FAERS
26MyalgiaFAERS: 2US FAERS
27Neuromuscular toxicityFAERS: 2US FAERS
28OliguriaFAERS: 2US FAERS
29Septic ShockFAERS: 2US FAERS
30Transaminases increasedFAERS: 2US FAERS
31AbasiaFAERS: 1US FAERS
32Abdominal Compartment SyndromeFAERS: 1US FAERS
33Accidental overdoseFAERS: 1US FAERS
34AgitationFAERS: 1US FAERS
35Alanine Aminotransferase IncreasedFAERS: 1US FAERS
36Altered state of consciousnessFAERS: 1US FAERS
37ArthralgiaFAERS: 1US FAERS
38Aspartate Aminotransferase IncreasedFAERS: 1US FAERS
39AstheniaFAERS: 1US FAERS
40Back PainFAERS: 1US FAERS
41BicytopeniaFAERS: 1US FAERS
42Blood lactate dehydrogenase increasedFAERS: 1US FAERS
43Bone marrow depressionFAERS: 1US FAERS
44Cardiac ArrestFAERS: 1US FAERS
45DeafnessFAERS: 1US FAERS
46Depressed Level of ConsciousnessFAERS: 1US FAERS
47EcchymosisFAERS: 1US FAERS
48Febrile NeutropeniaFAERS: 1US FAERS
49Fluid overloadFAERS: 1US FAERS
50GangreneFAERS: 1US FAERS
51Gastric ulcerFAERS: 1US FAERS
52HemiparesisFAERS: 1US FAERS
53Histiocytosis haematophagicFAERS: 1US FAERS
54IleusFAERS: 1US FAERS
55Joint swellingFAERS: 1US FAERS
56LethargyFAERS: 1US FAERS
57LeukopeniaFAERS: 1US FAERS
58Mental status changesFAERS: 1US FAERS
59Metabolic acidosisFAERS: 1US FAERS
60Myocardial InfarctionFAERS: 1US FAERS
61Neurological decompensationFAERS: 1US FAERS
62NeutropeniaFAERS: 1US FAERS
63Neutrophil morphology abnormalFAERS: 1US FAERS
64Oropharyngeal painFAERS: 1US FAERS
65PainFAERS: 1US FAERS
66PallorFAERS: 1US FAERS
67PoisoningFAERS: 1US FAERS
68PurpuraFAERS: 1US FAERS
69Respiratory distressFAERS: 1US FAERS
70RestlessnessFAERS: 1US FAERS
71Sinus bradycardiaFAERS: 1US FAERS
72TachycardiaFAERS: 1US FAERS
73ThrombocytosisFAERS: 1US FAERS
74Toxic Epidermal NecrolysisFAERS: 1US FAERS
75Weight decreasedFAERS: 1US FAERS
76White blood cell count decreasedFAERS: 1US FAERS
77jaundiceFAERS: 1US FAERS
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.